Australia's most trusted
source of pharma news
Thursday, 02 April 2026
Posted 1 April 2026 PM
Thirteen pharmas have won April PBS listings, with AstraZeneca, BMS, and MSD securing subsidy for more than one drug or multiple indications.
Overall, this month has been marked with 17 additions to the scheme, including seven novel drugs.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.